evidenceId,evidenceType,shortDesc,desc,id,lastEdit,status,gene/entrezGeneId,gene/hugoSymbol,gene/name,gene/oncogene,gene/curatedIsoform,gene/curatedRefSeq,gene/geneAliases/0,gene/geneAliases/1,gene/geneAliases/2,gene/tsg,articles/0/pmid,articles/0/title,articles/0/journal,articles/0/pubDate,articles/0/volume,articles/0/issue,articles/0/pages,articles/0/authors,articles/0/elocationId,articles/0/link,articles/0/reference,articles/0/abstract,articles/1/pmid,articles/1/title,articles/1/journal,articles/1/pubDate,articles/1/volume,articles/1/issue,articles/1/pages,articles/1/authors,articles/1/elocationId,articles/1/link,articles/1/reference,articles/1/abstract,articles/2/pmid,articles/2/title,articles/2/journal,articles/2/pubDate,articles/2/volume,articles/2/issue,articles/2/pages,articles/2/authors,articles/2/elocationId,articles/2/link,articles/2/reference,articles/2/abstract,articles/3/pmid,articles/3/title,articles/3/journal,articles/3/pubDate,articles/3/volume,articles/3/issue,articles/3/pages,articles/3/authors,articles/3/elocationId,articles/3/link,articles/3/reference,articles/3/abstract,articles/4/pmid,articles/4/title,articles/4/journal,articles/4/pubDate,articles/4/volume,articles/4/issue,articles/4/pages,articles/4/authors,articles/4/elocationId,articles/4/link,articles/4/reference,articles/4/abstract,articles/5/pmid,articles/5/title,articles/5/journal,articles/5/pubDate,articles/5/volume,articles/5/issue,articles/5/pages,articles/5/authors,articles/5/elocationId,articles/5/link,articles/5/reference,articles/5/abstract,articles/6/pmid,articles/6/title,articles/6/journal,articles/6/pubDate,articles/6/volume,articles/6/issue,articles/6/pages,articles/6/authors,articles/6/elocationId,articles/6/link,articles/6/reference,articles/6/abstract,articles/7/pmid,articles/7/title,articles/7/journal,articles/7/pubDate,articles/7/volume,articles/7/issue,articles/7/pages,articles/7/authors,articles/7/elocationId,articles/7/link,articles/7/reference,articles/7/abstract,articles/8/pmid,articles/8/title,articles/8/journal,articles/8/pubDate,articles/8/volume,articles/8/issue,articles/8/pages,articles/8/authors,articles/8/elocationId,articles/8/link,articles/8/reference,articles/8/abstract,articles/9/pmid,articles/9/title,articles/9/journal,articles/9/pubDate,articles/9/volume,articles/9/issue,articles/9/pages,articles/9/authors,articles/9/elocationId,articles/9/link,articles/9/reference,articles/9/abstract,articles/10/pmid,articles/10/title,articles/10/journal,articles/10/pubDate,articles/10/volume,articles/10/issue,articles/10/pages,articles/10/authors,articles/10/elocationId,articles/10/link,articles/10/reference,articles/10/abstract,articles/11/pmid,articles/11/title,articles/11/journal,articles/11/pubDate,articles/11/volume,articles/11/issue,articles/11/pages,articles/11/authors,articles/11/elocationId,articles/11/link,articles/11/reference,articles/11/abstract
8356,GENE_SUMMARY,,"ROS1, a receptor tyrosine kinase, is altered by mutation or chromosomal rearrangement in a diverse range of cancers, including lung cancer.",,2017-04-10,,6098,ROS1,"ROS proto-oncogene 1, receptor tyrosine kinase",True,ENST00000368508,NM_002944.2,MCF3,ROS,c-ros-1,False,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
8357,GENE_BACKGROUND,,"The ROS1 gene encodes a transmembrane protein with intracellular tyrosine kinase activity (PMID: 18778756). ROS1 is a member of the sevenless subfamily of tyrosine kinase insulin receptor genes (PMID: 27256160). The normal physiological role and ligand of this protein in humans is currently unknown (PMID: 23814043). ROS1 rearrangements where the kinase domain is retained (PMID: 22327623) are implicated in a range of human epithelial cancers including cholangiocarcinoma (PMID: 21253578), ovarian carcinoma (PMID: 22163003), gastric carcinoma (PMID: 23400546), angiosarcoma (PMID: 23637631) and most commonly non-small cell lung cancer (PMID: 22215748). Although ROS1 rearrangements were first discovered in a human glioblastoma cell line (PMID: 2827175), there is a paucity of ROS1 rearrangements in human gliomas (PMID: 24999209). The mechanism by which ROS1 rearrangements leads to dysregulated kinase activity is not clear, as its ligand has not yet been deciphered; however, it is hypothesized to occur through constitutive kinase activation (PMID: 18083107).",,2017-04-10,,6098,ROS1,"ROS proto-oncogene 1, receptor tyrosine kinase",True,ENST00000368508,NM_002944.2,MCF3,ROS,c-ros-1,False,27256160,ROS1 fusions in cancer: a review.,"Future oncology (London, England)",2018-08-01T20:16:00,12,16,1911-28,Uguen A et al,doi: 10.2217/fon-2016-0050,,0001-08-01,,18083107,Global survey of phosphotyrosine signaling identifies oncogenic kinases in lung cancer.,Cell,2017-12-14T20:07:00,131,6,1190-203,Rikova K et al,,,2017-12-14T02:03:00,,23400546,Identification of ROS1 rearrangement in gastric adenocarcinoma.,Cancer,2018-05-01T20:13:00,119,9,1627-35,Lee J et al,doi: 10.1002/cncr.27967,,0001-05-01,,23637631,Breakpoint analysis of transcriptional and genomic profiles uncovers novel gene fusions spanning multiple human cancer types.,PLoS genetics,2018-04-01T20:13:00,9,4,e1003464,Giacomini CP et al,doi: 10.1371/journal.pgen.1003464,,0001-04-01,,22327623,"RET, ROS1 and ALK fusions in lung cancer.",Nature medicine,2018-02-12T20:12:00,18,3,378-81,Takeuchi K et al,doi: 10.1038/nm.2658,,0001-02-12,,23814043,Novel targets in non-small cell lung cancer: ROS1 and RET fusions.,The oncologist,2013,18,7,865-75,Gainor JF et al,doi: 10.1634/theoncologist.2013-0095,,Gainor JF et al. The oncologist. 2013;18(7)865-75.,,2827175,Expression and rearrangement of the ROS1 gene in human glioblastoma cells.,Proceedings of the National Academy of Sciences of the United States of America,0001-12-01,84,24,9270-4,Birchmeier C et al,,,0001-12-01,,24999209,Lack of GOPC-ROS1 (FIG-ROS1) rearrangement in adult human gliomas.,"European journal of cancer (Oxford, England : 1990)",2018-09-01T20:14:00,50,13,2364-6,Karayan-Tapon L et al,doi: 10.1016/j.ejca.2014.06.001,,0001-09-01,,22163003,"Chromosome 3 anomalies investigated by genome wide SNP analysis of benign, low malignant potential and low grade ovarian serous tumours.",PloS one,2011,6,12,e28250,Birch AH et al,doi: 10.1371/journal.pone.0028250,,Birch AH et al. PloS one. 2011;6(12)e28250.,,22215748,ROS1 rearrangements define a unique molecular class of lung cancers.,Journal of clinical oncology : official journal of the American Society of Clinical Oncology,2018-03-10T20:12:00,30,8,863-70,Bergethon K et al,doi: 10.1200/JCO.2011.35.6345,,0001-03-10,,21253578,Survey of tyrosine kinase signaling reveals ROS kinase fusions in human cholangiocarcinoma.,PloS one,2018-01-06T20:11:00,6,True,e15640,Gu TL et al,doi: 10.1371/journal.pone.0015640,,0001-01-06,,18778756,The multifaceted roles of the receptor tyrosine kinase ROS in development and cancer.,Biochimica et biophysica acta,2018-01-01T20:09:00,1795,True,37-52,Acquaviva J et al,doi: 10.1016/j.bbcan.2008.07.006,,0001-01-01,
